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Nosocomial
Transmission of
Dengue 
To the Editor: Four viruses form
the dengue complex of mosquito-
borne viruses (family Flaviviridae,
genus Flavivirus). Any of these virus-
es can cause dengue fever, an uncom-
plicated febrile illness with rash; how-
ever, these viruses are not transmitted
person to person. The principal mos-
quito vector of these viruses is Aedes
aegypti. These viruses are not known
to exist in Europe; therefore, dengue
virus infections in Europe are seen in
patients returning from dengue-
endemic areas (1). Nosocomial trans-
missions of dengue viruses by needle-
stick have been reported in three
instances (2–4) and by bone marrow
transplant in one instance (5). We
describe the first case of nosocomial
dengue fever diagnosed and treated in
Hungary.
On September 6, 2003, a 46-year-
old physician sought care from the
Department of Infectology, (“Baranya
County Hospital” Pécs, Hungary); he
reported a 4-day history of fever,
headache, malaise, maculopapular
rash, and pharyngitis. He had recently
returned from a trip to Thailand and
recalled having been bitten by a mos-
quito at Bangkok airport 11 days ear-
lier. The patient had no history of ill-
nesses before he left Hungary to go to
Thailand. On examination, laboratory
results indicated leukopenia (3,300
leukocytes/mm3) and mild thrombo-
cytopenia (119,000 platelets/mm3).
Leukopenia is characteristic of
dengue virus and has been associated
with suppression of bone marrow pro-
duction (6). We conducted additional
tests because thrombocytopenia could
have been the first sign of a more
severe form of dengue infection,
dengue hemorrhagic fever, which is
associated with hemorrhagic diathesis
and shock (6). Lymphocytosis and
monocytosis with 26% atypical lym-
phocytes and a high-normal level of
alanine aminotransferase (56 U/L)
were found. The C-reactive protein
level and the erythrocyte sedimenta-
tion rate were normal. Blood smears
for malarial parasites were negative.
Examination of the patient showed
a maculopapular rash, pharyngitis,
and conjunctivitis. Dengue fever was
the clinical diagnosis based on the
patient’s history of a mosquito bite in
a dengue-endemic country, the
patient’s symptoms, and the laborato-
ry results. The patient’s general
condition was relatively good, so we
treated him on an outpatient basis and
recommended that he return for daily
examinations.
On September 7, while collecting a
blood sample from the patient, the
patient’s sister, also a physician, acci-
dentally stuck her finger with the nee-
dle, which was contaminated with the
patient’s blood. Seven days later she
became ill, with fever, headache, dif-
fuse maculopapular rash, myalgia,
cervical lymphadenopathy, and
malaise. Her laboratory tests showed
leukopenia with a normal thrombo-
cyte level, C-reactive protein level,
liver function tests, and erythrocyte
sedimentation rate. On physical
examination, painfully enlarged cervi-
cal lymph nodes and conjunctivitis
were found. No complications were
observed and the disease resolved
within 10 days after onset in both
patients. The female patient had never
traveled to a dengue-endemic region.
Serologic and virologic evidence
confirmed the clinical diagnosis.
Acute-phase serum samples from each
patient were tested for immunoglobu-
lin (Ig) M and IgG antibodies to
dengue viruses by using a commercial
enzyme-linked immunosorbent assay
kit. IgM, but not IgG, antibodies to
dengue viruses were detected in the
serum sample from the male patient 7
days after the onset of his illness; a
convalescent-phase serum sample was
not available for further testing. The
first serum sample was obtained from
the female patient 6 days after onset of
her illness. IgM and IgG antibodies
were not found in that sample. In the
serum sample obtained from the
female patient 12 days after onset,
IgM, but not IgG, antibodies to dengue
viruses were found. Both IgM and IgG
antibodies were found in serum sam-
ples from this patient 3 weeks after
onset of her illness.
Diagnosis was also confirmed by
reverse transcription–polymerase
chain reaction assays of early serum
samples of both patients by using uni-
versal flavivirus primers. Ampli-
fication products were directly
sequenced (GenBank accession no.
AY538627 and AY538628). The
nucleotide sequences were identified
with a BLAST search (http://www.
ncbi.nlm.nih.gov/BLAST/) using the
GenBank database. Highest similarity
was with dengue virus type 2 strain
ThNH76/93, which had been isolated
from a patient in northeast Thailand
during the epidemic season of 1993
(7). The virus- specific nucleotide
sequences detected in the Hungarian
patients showed 98% nucleotide iden-
tity with the corresponding sequences
of the Thai strain.
Viremia and simultaneous anti-
body production has been observed in
several studies of dengue (6,8,9).
Virus isolation is possible in dengue
infections early in the illness, and in
our experience, virus RNA wasLETTERS
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detected during the early febrile peri-
od. The male patient still had fever
when the needle accident occurred,
and the needle was contaminated.
Infectious disease specialists and
other physicians should recognize that
vector-borne diseases, such as dengue
and malaria, are potentially life threat-
ening. Therefore, they should consider
these diseases in the differential diag-
nosis of febrile patients returning from
tropical countries. In most patients,
dengue fever resolves without hemo-
concentration, an indication of dengue
hemorrhagic fever. Nosocomial trans-
mission of dengue viruses is not a
common event, however, physicians
must consider these diseases.
These unique cases demonstrate
the possible introduction and trans-
mission of exotic tropical viruses in a
country within temperate zones; all
that is needed are competent vectors.
Whereas A. aegypti is not endemic in
Europe, it could be introduced. The A.
albopictus mosquitoes, an invader
from Asia, already exists there, albeit
in isolated areas (10). Patients return-
ing from distant regions should be
treated with increased attention and
care. Although dengue viruses are
rarely transmitted person to person,
this incident emphasizes the impor-
tance of having reliable and rapid
diagnostic methods available for early
detection of imported infections with
exotic viral agents.
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Fever, Sénégal 
To the Editor: Crimean-Congo
hemorrhagic fever (CCHF) virus,
genus Nairovirus, family Bunyviridae,
is transmitted to mammals and birds
by ticks. Hyalomma ticks, the primary
vectors in CCHF transmission, are
widespread throughout Europe, Asia,
the Middle East, and Africa; evidence
of CCHF virus has been found in all
these regions. CCHF in humans is an
acute viral disease that is transmitted
by the bite of infected ticks, direct
contact with blood or infected tissues
from viremic animals, and direct con-
tact with the blood or secretions of an
infected person (1). 
On January 26, 2003, a 22-year-
old shepherd was treated at a health
post in the Popenguine District, 60 km
south of Dakar, Sénégal; he reported
fever, epistaxis, arthralgia, myalgia of
the lower limbs, and dark urine for the
past 2 days. Without biologic confir-
mation of the infection, he was treated
for malaria with two intravenous
injections of quinine, followed by oral
administration of chloroquine. 
On January 31, the patient had a
temperature of 39°C, conjunctival
jaundice, bleeding gums, and was
vomiting blood. He was seen again at
the health post and was given antimi-
crobial drugs, intravenous quinine,
and vitamin K; the next day, the
bleeding stopped and the fever sub-
sided. A serum sample was sent to the
World Health Organization
Collaborative Centre for Arboviruses
and Viral Hemorrhagic Fevers at the
Institut Pasteur, Dakar. Tests for anti-
CCHF specific immunoglobulin (Ig)
M antibody by enzyme-linked
immunosorbent assay (ELISA) were
positive, and CCHF virus by isolation
on cell cultures (AP61 and Vero cells)
and reverse transcriptase-polymerase
chain reaction (RT-PCR) were nega-
tive. From January 31 to February 10,
the IgM titer increased from 1/3,200
to >1/12,800 and IgG titer increased
from 1/200 to 1/6,400. 
Examination of the patient on
February 10 showed he had recovered
without sequelae, and no trace of tick
bites was found. The patient stated
that he had not traveled, noticed any
tick bites, slaughtered any animals, or